Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

James Humphreys

Showing results (21-30 of 30) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 30 results.
Vaccine|March 7, 2025
Effectiveness of COVID-19 vaccine against SARS-CoV-2 infection among symptomatic COVID-19 patients in UgandaAndrew M Abaasa, Sylvia Kusemererwa, Violet Ankunda, et al.
Vaccine|September 20, 2025
Effectiveness of JN.1 monovalent COVID-19 vaccination in EU/EEA countries between October 2024 and January 2025: a VEBIS electronic health record network studyJames Humphreys, Alexandre Blake, Nathalie Nicolay, et al.
Vaccine|March 7, 2025
COVID-19 vaccination status and associated factors among patients presenting with COVID-19-like symptoms in UgandaSylvia Kusemererwa, Violet Ankunda, Terry A Ongaria, et al.
The Lancet Regional Health. Europe|April 24, 2026
Comparing outcomes of COVID-19 and influenza among hospitalized adults in the European severe acute respiratory infection vaccine effectiveness (EuroSAVE) network, 2021-2024: a retrospective cohort analysisAmy Gimma, Kujtim Mersini, Olgha Tarkhan-Mouravi, et al.
Epidemiology and Infection|March 16, 2025
Comparison of two methods for the estimation of COVID-19 vaccine effectiveness of the autumnal booster within the VEBIS-EHR network in 2022/23Susana Monge, James Humphreys, Nathalie Nicolay, et al.
Influenza and Other Respiratory Viruses|April 24, 2024
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network StudySusana Monge, James Humphreys, Nathalie Nicolay, et al.
Influenza and Other Respiratory Viruses|June 18, 2025
COVID-19 Hospitalizations, Vaccine Uptake, Vaccination Guidelines, and Vaccine Availability in Six Middle-Income Countries and Areas in Europe, May 2022-April 2024Erin Rachel Whitehouse, Paul Elish, Elona Kureta, et al.
Viruses|January 8, 2025
Emerging SARS-CoV-2 Variants in Uganda in the Era of COVID-19 VaccinationNicholas Bbosa, Ronald Kiiza, Alfred Ssekagiri, et al.
The Lancet Regional Health. Europe|December 27, 2024
COVID-19 vaccine effectiveness against SARS-CoV-2-confirmed hospitalisation in the eastern part of the WHO European Region (2022-2023): a test-negative case-control study from the EuroSAVE networkMark A Katz, Sandra Cohuet, Silvia Bino, et al.
Vaccine|February 18, 2026
COVID-19 vaccine effectiveness against severe acute respiratory infections (SARI) hospitalisations associated with laboratory-confirmed SARS-CoV-2 in Ghana, June 2022 to March 2024Nicholas Amoako, Sandra Cohuet, Michael Rockson Adjei, et al.
Pageof 3

Showing results (21-30 of 30) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 30 results.
Vaccine|March 7, 2025
Effectiveness of COVID-19 vaccine against SARS-CoV-2 infection among symptomatic COVID-19 patients in UgandaAndrew M Abaasa, Sylvia Kusemererwa, Violet Ankunda, et al.
Vaccine|September 20, 2025
Effectiveness of JN.1 monovalent COVID-19 vaccination in EU/EEA countries between October 2024 and January 2025: a VEBIS electronic health record network studyJames Humphreys, Alexandre Blake, Nathalie Nicolay, et al.
Vaccine|March 7, 2025
COVID-19 vaccination status and associated factors among patients presenting with COVID-19-like symptoms in UgandaSylvia Kusemererwa, Violet Ankunda, Terry A Ongaria, et al.
The Lancet Regional Health. Europe|April 24, 2026
Comparing outcomes of COVID-19 and influenza among hospitalized adults in the European severe acute respiratory infection vaccine effectiveness (EuroSAVE) network, 2021-2024: a retrospective cohort analysisAmy Gimma, Kujtim Mersini, Olgha Tarkhan-Mouravi, et al.
Epidemiology and Infection|March 16, 2025
Comparison of two methods for the estimation of COVID-19 vaccine effectiveness of the autumnal booster within the VEBIS-EHR network in 2022/23Susana Monge, James Humphreys, Nathalie Nicolay, et al.
Influenza and Other Respiratory Viruses|April 24, 2024
Effectiveness of XBB.1.5 Monovalent COVID-19 Vaccines During a Period of XBB.1.5 Dominance in EU/EEA Countries, October to November 2023: A VEBIS-EHR Network StudySusana Monge, James Humphreys, Nathalie Nicolay, et al.
Influenza and Other Respiratory Viruses|June 18, 2025
COVID-19 Hospitalizations, Vaccine Uptake, Vaccination Guidelines, and Vaccine Availability in Six Middle-Income Countries and Areas in Europe, May 2022-April 2024Erin Rachel Whitehouse, Paul Elish, Elona Kureta, et al.
Viruses|January 8, 2025
Emerging SARS-CoV-2 Variants in Uganda in the Era of COVID-19 VaccinationNicholas Bbosa, Ronald Kiiza, Alfred Ssekagiri, et al.
The Lancet Regional Health. Europe|December 27, 2024
COVID-19 vaccine effectiveness against SARS-CoV-2-confirmed hospitalisation in the eastern part of the WHO European Region (2022-2023): a test-negative case-control study from the EuroSAVE networkMark A Katz, Sandra Cohuet, Silvia Bino, et al.
Vaccine|February 18, 2026
COVID-19 vaccine effectiveness against severe acute respiratory infections (SARI) hospitalisations associated with laboratory-confirmed SARS-CoV-2 in Ghana, June 2022 to March 2024Nicholas Amoako, Sandra Cohuet, Michael Rockson Adjei, et al.
Pageof 3